MAPK8 and cancer: As shown in Figure 4D, treatment of siRNAs against JNK1 and -2 in cancer cells (SKOV3 C8; OVCA433 C1) obviously down-regulated JNK1/2 expression compared to the scrambled siRNA controls, and the treatment subsequently suppressed the phosphorylation levels of JNK and its substrate c-Jun.